To investigate the intra-ocular pressure ( IOP ) - lowering effects of a selective Rho kinase inhibitor , ripasudil ( K-115 ) , over 24 hr in patients with primary open-angle glaucoma ( POAG ) or ocular hypertension ( OHT ) .